Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 119, Issue 4, Pages 605-611
Publisher
Wiley
Online
2016-10-15
DOI
10.1111/bju.13678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
- (2016) Venkata K. Pokuri et al. Clinical Genitourinary Cancer
- Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis
- (2016) Ahmed A. Hussein et al. UROLOGY
- Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
- (2015) Matthew D. Galsky et al. CANCER
- A review of relative dose intensity and survival in patients with metastatic solid tumors
- (2015) Laura J. Havrilesky et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
- (2015) Syed Johar Raza et al. EUROPEAN UROLOGY
- Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
- (2015) Bertram Yuh et al. EUROPEAN UROLOGY
- Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
- (2015) Timothy G. Wilson et al. EUROPEAN UROLOGY
- The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
- (2014) Harman M. Bruins et al. EUROPEAN UROLOGY
- The Effect of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients Who Have Bladder Cancer Treated with Radical Cystectomy: A Population-based Study
- (2014) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Complications After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
- (2013) Raza S. Johar et al. EUROPEAN UROLOGY
- Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis
- (2013) Fausto Petrelli et al. EUROPEAN UROLOGY
- Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
- (2012) Richard E. Hautmann et al. EUROPEAN UROLOGY
- Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study
- (2011) Hassan Abol-Enein et al. EUROPEAN UROLOGY
- Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer
- (2011) Robert Rosenblatt et al. EUROPEAN UROLOGY
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer
- (2010) A. Font et al. ANNALS OF ONCOLOGY
- Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy
- (2010) KYOUNG Ha KIM et al. APMIS
- Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
- (2010) Ganesh V. Raj et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now